LGALS3 and chronic myelogenous leukemia, BCR-ABL1 positive: In the case of LGALS1, a recent report characterized the induction of resistance to a variety of anticancer drugs following ectopic expression of galectin-3 in chronic myelogenous leukemia cells [30].